While patients with acute myeloid leukemia (AML) are routinely treated with chemotherapy and other cell-killing therapies, ...

Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced FDA approval to initiate COMPASSION-37/AK104-311 trial, a global multicenter Phase III trial in gastric cancer ...

Innovation is accelerating through bispecifics and dual payload strategies | Emerging ADC development approaches such as ...

Merck’s Keytruda, the category-defining CPI, reported $29.5 billion in revenue in 2024, with NSCLC representing an estimated 30% of its total sales. Keytruda is expected to approach $35 billion by ...

Marianne D'Amico-Ferrari has spent 29 years teaching in Trumbull. Families know her as steady and kind. Students describe her ...